Recent News

• 03.27.2025 - TriSalus Life Sciences Fourth Quarter 2024 Earnings Call
• 03.27.2025 - TriSalus Life Sciences Fourth Quarter 2024 Earnings Call
• 03.27.2025 - TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update
• 03.27.2025 - TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update
• 03.26.2025 - TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System Mapping
• 03.26.2025 - TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System Mapping
• 03.11.2025 - Richard Marshall
• 03.06.2025 - TriSalus Life Sciences® Announces That Its Researchers Received Two JVIR Top Paper Awards for the Publication of “Intra-arterial Pressure-Enabled Drug Delivery™ Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model”
• 03.06.2025 - TriSalus Life Sciences® Announces That Its Researchers Received Two JVIR Top Paper Awards for the Publication of “Intra-arterial Pressure-Enabled Drug Delivery™ Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model”
• 02.21.2025 - Gary Gordon

Recent Filings

• 03.27.2025 - EX-99.1 EX-99.1
• 03.27.2025 - 8-K Current report
• 02.25.2025 - 8-K Current report
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities